BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 28541790)

  • 1. Long-Lasting Increased Risk of Human Papillomavirus-Related Carcinomas and Premalignancies After Cervical Intraepithelial Neoplasia Grade 3: A Population-Based Cohort Study.
    Ebisch RMF; Rutten DWE; IntHout J; Melchers WJG; Massuger LFAG; Bulten J; Bekkers RLM; Siebers AG
    J Clin Oncol; 2017 Aug; 35(22):2542-2550. PubMed ID: 28541790
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The relative risk of noncervical high-risk human papillomavirus-related (pre)malignancies after recurrent cervical intraepithelial neoplasia grade 3: A population-based study.
    Loopik DL; Ebisch RM; IntHout J; Melchers WJ; Massuger LF; Bekkers RL; Siebers AG
    Int J Cancer; 2020 Aug; 147(3):897-900. PubMed ID: 31846057
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-Term Risk for Noncervical Anogenital Cancer in Women with Previously Diagnosed High-Grade Cervical Intraepithelial Neoplasia: A Danish Nationwide Cohort Study.
    Sand FL; Munk C; Jensen SM; Svahn MF; Frederiksen K; Kjær SK
    Cancer Epidemiol Biomarkers Prev; 2016 Jul; 25(7):1090-7. PubMed ID: 27358257
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased risk of HPV-associated genital cancers in men and women as a consequence of pre-invasive disease.
    Pan J; Kavanagh K; Cuschieri K; Pollock KG; Gilbert DC; Millan D; Bell S; Graham SV; Williams ARW; Cruickshank ME; Palmer T; Wakeham K
    Int J Cancer; 2019 Jul; 145(2):427-434. PubMed ID: 30650180
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human papillomavirus-related anogenital premalignancies and cancer in renal transplant recipients: A Danish nationwide, registry-based cohort study.
    Reinholdt K; Thomsen LT; Dehlendorff C; Larsen HK; Sørensen SS; Haedersdal M; Kjaer SK
    Int J Cancer; 2020 May; 146(9):2413-2422. PubMed ID: 31291470
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incidence of ano-genital and head and neck malignancies in women with a previous diagnosis of cervical intraepithelial neoplasia.
    Gaudet M; Hamm J; Aquino-Parsons C
    Gynecol Oncol; 2014 Sep; 134(3):523-6. PubMed ID: 25042671
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk of anogenital cancer after diagnosis of cervical intraepithelial neoplasia: a prospective population-based study.
    Edgren G; Sparén P
    Lancet Oncol; 2007 Apr; 8(4):311-6. PubMed ID: 17395104
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ten-year follow-up of human papillomavirus vaccine efficacy against the most stringent cervical neoplasia end-point-registry-based follow-up of
    Lehtinen M; Lagheden C; Luostarinen T; Eriksson T; Apter D; Harjula K; Kuortti M; Natunen K; Palmroth J; Petäjä T; Pukkala E; Siitari-Mattila M; Struyf F; Nieminen P; Paavonen J; Dubin G; Dillner J
    BMJ Open; 2017 Aug; 7(8):e015867. PubMed ID: 28821519
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prophylactic vaccination against human papillomaviruses to prevent cervical cancer and its precursors.
    Arbyn M; Xu L; Simoens C; Martin-Hirsch PP
    Cochrane Database Syst Rev; 2018 May; 5(5):CD009069. PubMed ID: 29740819
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multizonal anogenital neoplasia in women: a cohort analysis.
    Albuquerque A; Godfrey MAL; Cappello C; Pesola F; Bowring J; Cuming T; De Masi A; Rosenthal AN; Sasieni P; Nathan M
    BMC Cancer; 2021 Mar; 21(1):232. PubMed ID: 33676451
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk of cervical precancer among HPV-negative women in the Netherlands and its association with previous HPV and cytology results: A follow-up analysis of a randomized screening study.
    Inturrisi F; Rozendaal L; Veldhuijzen NJ; Heideman DAM; Meijer CJLM; Berkhof J
    PLoS Med; 2022 Oct; 19(10):e1004115. PubMed ID: 36306283
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk of vulvar, vaginal and anal high-grade intraepithelial neoplasia and cancer according to cervical human papillomavirus (HPV) status: A population-based prospective cohort study.
    Bertoli HK; Thomsen LT; Iftner T; Dehlendorff C; Kjær SK
    Gynecol Oncol; 2020 May; 157(2):456-462. PubMed ID: 32008794
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Updating the natural history of human papillomavirus and anogenital cancers.
    Moscicki AB; Schiffman M; Burchell A; Albero G; Giuliano AR; Goodman MT; Kjaer SK; Palefsky J
    Vaccine; 2012 Nov; 30 Suppl 5(0 5):F24-33. PubMed ID: 23199964
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human papillomavirus genotype attribution for HPVs 6, 11, 16, 18, 31, 33, 45, 52 and 58 in female anogenital lesions.
    Serrano B; de Sanjosé S; Tous S; Quiros B; Muñoz N; Bosch X; Alemany L
    Eur J Cancer; 2015 Sep; 51(13):1732-41. PubMed ID: 26121913
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term absolute risk of cervical intraepithelial neoplasia grade 3 or worse following human papillomavirus infection: role of persistence.
    Kjær SK; Frederiksen K; Munk C; Iftner T
    J Natl Cancer Inst; 2010 Oct; 102(19):1478-88. PubMed ID: 20841605
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HPV testing compared with routine cytology in cervical screening: long-term follow-up of ARTISTIC RCT.
    Gilham C; Sargent A; Kitchener HC; Peto J
    Health Technol Assess; 2019 Jun; 23(28):1-44. PubMed ID: 31219027
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of Screening With Primary Cervical HPV Testing vs Cytology Testing on High-grade Cervical Intraepithelial Neoplasia at 48 Months: The HPV FOCAL Randomized Clinical Trial.
    Ogilvie GS; van Niekerk D; Krajden M; Smith LW; Cook D; Gondara L; Ceballos K; Quinlan D; Lee M; Martin RE; Gentile L; Peacock S; Stuart GCE; Franco EL; Coldman AJ
    JAMA; 2018 Jul; 320(1):43-52. PubMed ID: 29971397
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The risk of cervical cancer after cervical intraepithelial neoplasia grade 3: A population-based cohort study with 80,442 women.
    Loopik DL; IntHout J; Ebisch RMF; Melchers WJG; Massuger LFAG; Siebers AG; Bekkers RLM
    Gynecol Oncol; 2020 Apr; 157(1):195-201. PubMed ID: 31973912
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety of extending screening intervals beyond five years in cervical screening programmes with testing for high risk human papillomavirus: 14 year follow-up of population based randomised cohort in the Netherlands.
    Dijkstra MG; van Zummeren M; Rozendaal L; van Kemenade FJ; Helmerhorst TJ; Snijders PJ; Meijer CJ; Berkhof J
    BMJ; 2016 Oct; 355():i4924. PubMed ID: 27702796
    [TBL] [Abstract][Full Text] [Related]  

  • 20. p16 Immunohistochemistry is useful in confirming high-grade squamous intraepithelial lesions (HSIL) in women with negative HPV testing.
    Zhang G; Yang B; Abdul-Karim FW
    Int J Gynecol Pathol; 2015 Mar; 34(2):180-6. PubMed ID: 25675189
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.